(Q33850477)

29 July 2017

1 reference

title

Arrhythmias in heart failure: current concepts of mechanisms and therapy (English)

1 reference

29 July 2017

1 reference

Eckardt L

1

1 reference

29 July 2017

Haverkamp W

2

1 reference

29 July 2017

Johna R

3

1 reference

29 July 2017

Böcker D

4

1 reference

29 July 2017

Deng MC

5

1 reference

29 July 2017

Breithardt G

6

1 reference

29 July 2017

Borggrefe M

7

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Journal of Cardiovascular Electrophysiology

29 July 2017

published in

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

106-117

1 reference

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Biochemical and electrophysiological alterations underlying ventricular arrhythmias in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Potassium channel down-regulation in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Ca2+i transients in the cardiomyopathic hamster heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Decreased spontaneous heart rate variability in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Potassium and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Hormone-electrolyte interactions in congestive heart failure: lessons from a 4,000-year-old Sumerian tablet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Arrhythmias and mortality in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

The clinical significance of nonsustained ventricular tachycardia: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Significance of aborted cardiac arrest and sustained ventricular tachycardia in patients referred for treatment therapy of advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Factors influencing the one-year mortality of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Prediction of arrhythmia risk based on signal-averaged ECG in postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Programmed electrical stimulation and long-term follow-up in asymptomatic, nonsustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Value of electrophysiologic testing in patients with nonsustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Experimental models of torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Four chamber pacing in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Acute hemodynamic effects of atrio-biventricular pacing in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Low-dose amiodarone for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Amiodarone and torsades de pointes in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

Conduction block in the inferior vena caval-tricuspid valve isthmus: Association with outcome of radiofrequency ablation of type I atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.2000.TB00746.X

10.1111/J.1540-8167.2000.TB00746.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference